Andrew M. Hau, Ph.D.
Affiliations: | 2013 | Oregon State University, Corvallis, OR |
Area:
Pharmacology, Cell Biology, Molecular BiologyGoogle:
"Andrew Hau"Parents
Sign in to add mentor| Jane E. Ishmael | grad student | 2013 | Oregon State | |
| (Biological Characterization of Coibamide A, a Marine Natural Product from a Panamanian Cyanobacterium.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hau AM, Gupta S, Leivo MZ, et al. (2019) Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells. The American Journal of Pathology |
| Hau AM, Nakasaki M, Nakashima K, et al. (2017) Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition. Urologic Oncology |
| Sahu D, Gupta S, Hau AM, et al. (2016) Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase. The American Journal of Pathology |
| Hau AM, Leivo MZ, Gilder AS, et al. (2016) mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. Cellular Signalling |
| Gupta S, Hau AM, Al-Ahmadie HA, et al. (2016) Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. The American Journal of Pathology |
| Hau AM, Gilder A, Hu J, et al. (2016) uPAR and mTORC2 as coupled targets for therapeutics development in bladder cancer. Journal of Clinical Oncology. 34: 447-447 |
| Serrill JD, Wan X, Hau AM, et al. (2015) Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts. Investigational New Drugs |
| Serrill JD, Tan M, Fotso S, et al. (2015) Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A Biochemical Pharmacology. 93: 251-265 |
| Nabika R, Suyama TL, Hau AM, et al. (2015) Synthesis and biological evaluation of the [d-MeAla(11)]-epimer of coibamide A. Bioorganic & Medicinal Chemistry Letters. 25: 302-6 |
| Sahu D, Gupta S, Hau AM, et al. (2015) Abstract 4712: Targeting the arginine-nitric oxide pathway to arrest development and progression of invasive bladder cancer Cancer Research. 75: 4712-4712 |